IndiaMTF — home
Stock

Orchid Pharma — MTF Book

ORCHPHARMA · Orchid Pharma Limited
Health Technology

Daily Margin Trading Facility book for Orchid Pharma across NSE and BSE, from 03 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.

What is Orchid Pharma’s MTF book?

Orchid Pharma Limited (ORCHPHARMA) has ₹20 crore funded under Margin Trading Facility across NSE and BSE as of 15 Jul 2026 — 0.01% of India’s MTF book, ranking #982.

Funded value
₹20 Cr
as of 15 Jul 2026
Rank in book
#982
141 days tracked
Share of book
0.01%
of the whole NSE + BSE book
Peak funded
₹115 Cr
on 03 Aug 2017
Largest single-day addition
+₹7 Cr
on 02 Apr 2025
Largest single-day unwind
−₹115 Cr
on 04 Aug 2017
Free-float market cap
₹1,252 Cr
full market cap ₹4,901 Cr · 25.6% free float · Small cap
MTF share of free float
1.37%
0.6× the median small cap · 1.6× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.32%0.76%1.20%1.65%Apr 2025Jul 2026
View as table: share of free float on margin11 months
Month-end% of free float
15 Jul 2026†1.370%
18 Jun 2026†1.258%
17 Apr 2026†1.333%
30 Mar 20261.393%
26 Feb 2026†1.173%
30 Jan 20261.157%
31 Dec 20251.493%
28 Nov 20251.374%
05 Jun 2025†0.819%
30 May 20250.728%
25 Apr 2025†0.473%

† Not the month’s last trading day: the last day the stock was in the archive that month (before 11 Nov 2025 the archive kept only the 500 largest positions).

Dated events

NSE & BSE split

How ORCHPHARMA’s funded book divides across the two exchanges, as of 15 Jul 2026.
NSE
NSE ₹19 Cr · 97.5%BSE ₹0 Cr · 2.5%

MTF vs Price

Margin-funded outstanding for ORCHPHARMA in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where ORCHPHARMA has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

ORCHPHARMA — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
15 Jul 202620+₹10.01%982
14 Jul 202619+₹00.01%993
08 Jul 202619+₹20.01%985
18 Jun 202617+₹00.01%998
17 Jun 202616+₹00.01%996
11 Jun 202616+₹20.01%986
17 Apr 202614−₹10.01%992
16 Apr 202615+₹00.01%966
15 Apr 202615+₹00.01%964
13 Apr 202615+₹00.01%961
10 Apr 202615+₹00.01%959
09 Apr 202614+₹00.01%966
08 Apr 202614−₹00.01%962
07 Apr 202615+₹00.01%956
06 Apr 202614−₹00.01%961
02 Apr 202615−₹00.01%960
01 Apr 202615−₹00.01%953
30 Mar 202615−₹00.01%945
27 Mar 202615−₹00.01%948
25 Mar 202616+₹10.01%941
24 Mar 202615+₹00.01%952
23 Mar 202615−₹00.01%956
20 Mar 202615−₹00.01%959
19 Mar 202615+₹00.01%955
18 Mar 202615+₹00.01%954
17 Mar 202615+₹00.01%955
16 Mar 202615+₹00.01%963
13 Mar 202615+₹00.01%968
12 Mar 202615−₹00.01%964
11 Mar 202615—0.01%963
Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.